Celularity Receives Notice From Nasdaq; Confirms Intention To File An Appeal
Portfolio Pulse from Benzinga Newsdesk
Celularity Inc. (NASDAQ:CELU) has received a delisting notice from Nasdaq due to delayed filing of its Forms 10-Q for Q1 and Q2 2024. The company plans to appeal and present a compliance plan. The stock continues to trade on Nasdaq.
October 18, 2024 | 10:51 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Celularity Inc. received a delisting notice from Nasdaq for not filing its Q1 and Q2 2024 Forms 10-Q on time. The company plans to appeal and present a compliance plan.
The delisting notice from Nasdaq is a significant regulatory issue that could negatively impact investor confidence and the stock price in the short term. The company's intention to appeal and file the missing reports may mitigate some negative effects, but uncertainty remains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100